New treatment for multiple myeloma
The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of adult patients with multiple myeloma. Isatuximab-irfc was previously…
Oncology
Study examines rate of cancer overdiagnosis in Australia
A recent study published in the Medical Journal of Australia examined the “proportion of cancer diagnoses in Australia that might reasonably be attributed to…
New vaccine eliminated breast cancer in first human patient
A vaccine being developed in the Mayo Clinic in Jacksonville, Florida is aimed at preventing new cases of ovarian and breast cancer and even…
The World Health Organization aims to reduce mortality of cervical cancer
In a recent study, the World Health Organization (WHO) describes a study which aims to eliminate cervical cancer “as a public health problem.” (more…)
New treatment for advanced epithelioid sarcoma
The U.S. Food and Drug Administration (FDA) recently approved Epizyme, Inc’s tazemetostat (TAZVERIK) for the treatment of adult and pediatric patients with metastatic or…
Take Care of Yourself
How many of you hear the phrase “self-care” and roll your eyes? I know. Because that’s my reaction, too. As if nurses’ endless task…
New findings from the American Cancer Society on reduced cancer mortality rates
Based on new findings from a 2020 American Cancer Society report, mortality rates from cancer have declined by 29% between 1991 to 2017 in…
Oncology nursing core competencies
As more patients survive cancer, nursing education must meet the demand for nurses who can care for them. Takeaways: At the same time that…
Accelerated approval for new sickle cell disease treatment
The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to Global Blood Therapeutics’ voxelotor (Oxbryta), a treatment for adults and pediatric patients…
Pragmatic dissemination and implementation hybrid research
Innovative study designs examine implementation and generate new knowledge. Takeaways: Some organizations struggle to meet Magnet® nurse research requirements. Many research efforts result in…
Accelerated approval for a new mantle cell lymphoma drug
The Food and Drug Administration (FDA) has recently granted accelerated approval to BeiGene’s mantle cell lymphoma (MCL) oral therapy, zanubritinib (BRUKINSA). (more…)
American Heart Association: E-cigarettes are not safe alternative
The American Heart Association (AHA) recently held its 2019 Scientific Sessions in Philadelphia PA. The sessions covered many topics, but one of the most…
New treatment for multiple myeloma
The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of adult patients with multiple myeloma. Isatuximab-irfc…
Study examines rate of cancer overdiagnosis in Australia
A recent study published in the Medical Journal of Australia examined the “proportion of cancer diagnoses in Australia that might reasonably be…
New vaccine eliminated breast cancer in first human patient
A vaccine being developed in the Mayo Clinic in Jacksonville, Florida is aimed at preventing new cases of ovarian and breast cancer…
The World Health Organization aims to reduce mortality of cervical cancer
In a recent study, the World Health Organization (WHO) describes a study which aims to eliminate cervical cancer “as a public health…
New treatment for advanced epithelioid sarcoma
The U.S. Food and Drug Administration (FDA) recently approved Epizyme, Inc’s tazemetostat (TAZVERIK) for the treatment of adult and pediatric patients with…
Take Care of Yourself
How many of you hear the phrase “self-care” and roll your eyes? I know. Because that’s my reaction, too. As if nurses’…
New findings from the American Cancer Society on reduced cancer mortality rates
Based on new findings from a 2020 American Cancer Society report, mortality rates from cancer have declined by 29% between 1991 to…
Oncology nursing core competencies
As more patients survive cancer, nursing education must meet the demand for nurses who can care for them. Takeaways: At the same…
Accelerated approval for new sickle cell disease treatment
The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to Global Blood Therapeutics’ voxelotor (Oxbryta), a treatment for adults and…
Pragmatic dissemination and implementation hybrid research
Innovative study designs examine implementation and generate new knowledge. Takeaways: Some organizations struggle to meet Magnet® nurse research requirements. Many research efforts…
Accelerated approval for a new mantle cell lymphoma drug
The Food and Drug Administration (FDA) has recently granted accelerated approval to BeiGene’s mantle cell lymphoma (MCL) oral therapy, zanubritinib (BRUKINSA). (more…)
American Heart Association: E-cigarettes are not safe alternative
The American Heart Association (AHA) recently held its 2019 Scientific Sessions in Philadelphia PA. The sessions covered many topics, but one of…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.